Global Patient Support Programs (PSP) Market Size is valued at USD 21.8 Billion in 2024 and is predicted to reach USD 104.7 Billion by the year 2034 at a 17.1% CAGR during the forecast period for 2025-2034.
The patient support programs (PSP) market is a rapidly expanding segment of the healthcare and pharmaceutical industries, driven by an increased emphasis on patient-centric care and the desire to improve treatment outcomes. PSPs are in high demand as healthcare becomes more patient-centred. Patients want more than just medication; they want information, support, and resources to manage their health issues effectively. PSPs are particularly common in treating chronic diseases such as diabetes, cancer, and autoimmune disorders.
These programs assist patients in adhering to treatment plans, dealing with side effects, and improving their overall quality of life. The rising frequency of chronic diseases, increased patient demand for comprehensive care, and the use of technology for remote monitoring and participation. Pharmaceutical companies see PSPs as improving patient outcomes while building brand loyalty. PSP providers face regulatory compliance and patient data privacy problems. It can be difficult to secure patient information while navigating complex healthcare legislation.
The PSP market has significant room for expansion, particularly in emerging economies. Digital health technology advancements and growing engagement with healthcare providers present the potential for further innovation and expansion. PSPs can improve patient adherence, overall health outcomes, and healthcare experience, making them an important part of modern healthcare delivery.
The Patient Support Programs (PSP) market is segmented based on Functionality, Therapeutic area, Application, and End User. As per the Functionality, the market is segmented as communication, health tracking & insights, billing & payments, administrative support, and patient education. By Therapeutic area, the market is segmented into Health & Wellness and Chronic Disease Management, and other therapeutic area. The market is segmented by application into Population Health Management, Outpatient Health Management, In-patient Health Management, and others. By end user, the market is segmented into payers, providers, and others.
The health tracking & insights category will hold a major share of the global Patient Support Programs (PSP) market 2024. Frequently integrated into digital health solutions, these technologies provide real-time monitoring and data collecting, allowing for individualized care and patient interaction. Data-driven health insights enable healthcare professionals and pharmaceutical businesses to personalize support packages to particular patient needs. This not only improves medication adherence and overall health outcomes, but it also increases the efficacy of PSPs. As a result, including Health Tracking and insights into PSPs is becoming increasingly important, contributing to market growth by offering more targeted and efficient patient support.
The population health management segment is estimated to grow rapidly in the global Patient Support Programs (PSP) market PHM techniques are designed to improve the health of entire patient groups, making them an excellent complement to PSPs. PHM enables healthcare providers and payers to identify at-risk individuals and design PSPs to their specific requirements by leveraging data analytics, care coordination, and patient engagement strategies. This proactive strategy improves patient outcomes while simultaneously lowering healthcare expenses. As more healthcare systems embrace PHM, the synergy between PHM and PSPs propels market expansion by providing more efficient, cost-effective, patient-centered care.
The North America Patient Support Programs (PSP) market is leading region. The region is known for its high prevalence of chronic diseases, aging population, and advanced healthcare infrastructure. Furthermore, North American pharmaceutical companies and healthcare providers are rapidly realizing the importance of PSPs in enhancing patient outcomes and satisfaction. Regulatory frameworks and reimbursement mechanisms also aid the adoption of such solutions. North America continues to drive the expansion of the PSP industry, ultimately resulting in better healthcare delivery and patient experiences, with a strong emphasis on patient-centric care, combined with the region's technology prowess and financial investment capability.
In addition, Asia Pacific is projected to grow rapidly in the global Patient Support Programs (PSP) market. Because of the expanding frequency of chronic diseases, increased healthcare investment, and the adoption of patient-centered care, there are prospects for PSP expansion in the region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 21.8 Billion |
|
Revenue Forecast In 2034 |
USD 104.7 Billion |
|
Growth Rate CAGR |
CAGR of 17.1% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Functionality, Therapeutic Area, Application and End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Allscripts Healthcare, LLC; Orion Health; Cerner Corporation; McKesson Corporation; athenahealth, Inc.; IBM; Medecision; GetWellNetwork, Inc.; MEDHOST; Lincor; IQVIA; Wolters Kluwer N.V.; Force Therapeutics LLC; Quil; Greenway Health, LLC; Mytonomy; Klara Technologies, Inc.; Solutionreach, Inc.; CureMD Healthcare; Patient point LLC; Vivify Health; Nuance Communications, Inc. and others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Patient Support Programs (PSP) Market Snapshot
Chapter 4. Global Patient Support Programs (PSP) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Functionality Estimates & Trend Analysis
5.1. By Functionality, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Functionality:
5.2.1. Communication
5.2.2. Health Tracking & Insights
5.2.3. Billing & Payments
5.2.4. Administrative
5.2.5. Patient Education
5.2.6. Others
Chapter 6. Market Segmentation 2: By Therapeutic area Estimates & Trend Analysis
6.1. By Therapeutic area & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic area:
6.2.1. Health & Wellness
6.2.2. Chronic Disease Management
6.2.3. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
7.2.1. Population Health Management
7.2.2. Outpatient Health Management
7.2.3. In-patient Health Management
7.2.4. Others
Chapter 8. Market Segmentation 4: By End-user Estimates & Trend Analysis
8.1. By End-user & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:
8.2.1. Payers
8.2.2. Providers
8.2.3. Others
Chapter 9. Patient Support Programs (PSP) Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Functionality, 2021-2034
9.1.2. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Therapeutic area, 2021-2034
9.1.3. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.1.4. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
9.1.5. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, 2021-2034
9.2.2. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, 2021-2034
9.2.3. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Application, 2021-2034
9.2.4. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, 2021-2034
9.2.5. Europe Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, 2021-2034
9.3.2. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, 2021-2034
9.3.3. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Application, 2021-2034
9.3.4. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, 2021-2034
9.3.5. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, (US$ Million) 2021-2034
9.4.2. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, (US$ Million) 2021-2034
9.4.3. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
9.4.4. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
9.4.5. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality (US$ Million) 2021-2034
9.5.2. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Application (US$ Million) 2021-2034
9.5.4. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
9.5.5. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Allscripts Healthcare, LLC
10.2.2. Orion Health
10.2.3. Cerner Corporation
10.2.4. McKesson Corporation
10.2.5. athenahealth, Inc.
10.2.6. IBM
10.2.7. Medecision
10.2.8. GetWellNetwork, Inc.
10.2.9. MEDHOST
10.2.10. Lincor
10.2.11. IQVIA
10.2.12. Wolters Kluwer N.V.
10.2.13. Force Therapeutics LLC
10.2.14. Quil
10.2.15. Greenway Health, LLC
10.2.16. Mytonomy
10.2.17. Klara Technologies, Inc.
10.2.18. Solutionreach, Inc.
10.2.19. CureMD Healthcare
10.2.20. Patient point LLC
10.2.21. Vivify Health
10.2.22. Nuance Communications, Inc.
Patient Support Programs (PSP) Market By Functionality-
Patient Support Programs (PSP) Market By Therapeutic area-
Patient Support Programs (PSP) Market By Application-
Patient Support Programs (PSP) Market By End-user-
Patient Support Programs (PSP) Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
